Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models

Matthew D. Hall, Catherine Martin, David J P Ferguson, Roger M. Phillips, Trevor W. Hambley, Richard Callaghan

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Platinum(II)-based anticancer drugs are associated with high reactivity and thus a poor biological stability. The platinum(IV)-complexes display potential advantages due to their greater stability and bioreductive activation, thereby allowing a greater proportion of the drug to arrive at the target intact. All compounds tested were able to produce cytotoxicity in monolayer cell cultures, however, the potencies of platinum(IV) drugs were lower than that observed for the platinum(II) compounds or established organic chemotherapeutic agents. There was no significant alteration in the potency of platinum(II) or (IV) compounds to produce cytotoxicity in multicellular tumour spheroids (MCTS) compared to monolayer cultures. All the organic and platinum-based cytotoxic agents produced, to varying degrees, either a retardation or reduction in MCTS growth. Proliferating cells were restricted to the outer two to three cellular layers in intermediate (d=350μm) and large (d=600μm) MCTS. Regardless of MCTS size, drug treatment produced a larger and more widely distributed proliferating cell population, consistent with the recruitment of quiescent cells to the proliferating pool following cytotoxic damage. Histology indicated that the predominant morphological change was that of apoptosis, although there was some drug-dependent effects such as the metaphase arrest produced by vinblastine and chromatin dispersal to the periphery of nuclei produced by doxorubicin. In summary, whilst the platinum(IV) derivatives were able to produce cytotoxicity via apoptosis, the introduction of a stable axial group significantly retarded the rate at which this occurred.

Original languageEnglish
Pages (from-to)17-30
Number of pages14
JournalBiochemical Pharmacology
Volume67
Issue number1
Early online date30 Oct 2003
DOIs
Publication statusPublished - 1 Jan 2004
Externally publishedYes

Fingerprint

Platinum Compounds
Platinum
Cellular Spheroids
Tumors
Cytotoxicity
Pharmaceutical Preparations
Neoplasms
Monolayers
Platinum compounds
Apoptosis
Drug therapy
Histology
Vinblastine
Cytotoxins
Metaphase
Cell culture
Doxorubicin
Chromatin
Cell Culture Techniques
Chemical activation

Cite this

Hall, Matthew D. ; Martin, Catherine ; Ferguson, David J P ; Phillips, Roger M. ; Hambley, Trevor W. ; Callaghan, Richard. / Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models. In: Biochemical Pharmacology. 2004 ; Vol. 67, No. 1. pp. 17-30.
@article{b6cc3860305b4dbea265d7cbab4b906f,
title = "Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models",
abstract = "Platinum(II)-based anticancer drugs are associated with high reactivity and thus a poor biological stability. The platinum(IV)-complexes display potential advantages due to their greater stability and bioreductive activation, thereby allowing a greater proportion of the drug to arrive at the target intact. All compounds tested were able to produce cytotoxicity in monolayer cell cultures, however, the potencies of platinum(IV) drugs were lower than that observed for the platinum(II) compounds or established organic chemotherapeutic agents. There was no significant alteration in the potency of platinum(II) or (IV) compounds to produce cytotoxicity in multicellular tumour spheroids (MCTS) compared to monolayer cultures. All the organic and platinum-based cytotoxic agents produced, to varying degrees, either a retardation or reduction in MCTS growth. Proliferating cells were restricted to the outer two to three cellular layers in intermediate (d=350μm) and large (d=600μm) MCTS. Regardless of MCTS size, drug treatment produced a larger and more widely distributed proliferating cell population, consistent with the recruitment of quiescent cells to the proliferating pool following cytotoxic damage. Histology indicated that the predominant morphological change was that of apoptosis, although there was some drug-dependent effects such as the metaphase arrest produced by vinblastine and chromatin dispersal to the periphery of nuclei produced by doxorubicin. In summary, whilst the platinum(IV) derivatives were able to produce cytotoxicity via apoptosis, the introduction of a stable axial group significantly retarded the rate at which this occurred.",
keywords = "Apoptosis, Chemotherapy, Platinum drugs, Solid tumour models",
author = "Hall, {Matthew D.} and Catherine Martin and Ferguson, {David J P} and Phillips, {Roger M.} and Hambley, {Trevor W.} and Richard Callaghan",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/j.bcp.2003.07.016",
language = "English",
volume = "67",
pages = "17--30",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "1",

}

Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models. / Hall, Matthew D.; Martin, Catherine; Ferguson, David J P; Phillips, Roger M.; Hambley, Trevor W.; Callaghan, Richard.

In: Biochemical Pharmacology, Vol. 67, No. 1, 01.01.2004, p. 17-30.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models

AU - Hall, Matthew D.

AU - Martin, Catherine

AU - Ferguson, David J P

AU - Phillips, Roger M.

AU - Hambley, Trevor W.

AU - Callaghan, Richard

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Platinum(II)-based anticancer drugs are associated with high reactivity and thus a poor biological stability. The platinum(IV)-complexes display potential advantages due to their greater stability and bioreductive activation, thereby allowing a greater proportion of the drug to arrive at the target intact. All compounds tested were able to produce cytotoxicity in monolayer cell cultures, however, the potencies of platinum(IV) drugs were lower than that observed for the platinum(II) compounds or established organic chemotherapeutic agents. There was no significant alteration in the potency of platinum(II) or (IV) compounds to produce cytotoxicity in multicellular tumour spheroids (MCTS) compared to monolayer cultures. All the organic and platinum-based cytotoxic agents produced, to varying degrees, either a retardation or reduction in MCTS growth. Proliferating cells were restricted to the outer two to three cellular layers in intermediate (d=350μm) and large (d=600μm) MCTS. Regardless of MCTS size, drug treatment produced a larger and more widely distributed proliferating cell population, consistent with the recruitment of quiescent cells to the proliferating pool following cytotoxic damage. Histology indicated that the predominant morphological change was that of apoptosis, although there was some drug-dependent effects such as the metaphase arrest produced by vinblastine and chromatin dispersal to the periphery of nuclei produced by doxorubicin. In summary, whilst the platinum(IV) derivatives were able to produce cytotoxicity via apoptosis, the introduction of a stable axial group significantly retarded the rate at which this occurred.

AB - Platinum(II)-based anticancer drugs are associated with high reactivity and thus a poor biological stability. The platinum(IV)-complexes display potential advantages due to their greater stability and bioreductive activation, thereby allowing a greater proportion of the drug to arrive at the target intact. All compounds tested were able to produce cytotoxicity in monolayer cell cultures, however, the potencies of platinum(IV) drugs were lower than that observed for the platinum(II) compounds or established organic chemotherapeutic agents. There was no significant alteration in the potency of platinum(II) or (IV) compounds to produce cytotoxicity in multicellular tumour spheroids (MCTS) compared to monolayer cultures. All the organic and platinum-based cytotoxic agents produced, to varying degrees, either a retardation or reduction in MCTS growth. Proliferating cells were restricted to the outer two to three cellular layers in intermediate (d=350μm) and large (d=600μm) MCTS. Regardless of MCTS size, drug treatment produced a larger and more widely distributed proliferating cell population, consistent with the recruitment of quiescent cells to the proliferating pool following cytotoxic damage. Histology indicated that the predominant morphological change was that of apoptosis, although there was some drug-dependent effects such as the metaphase arrest produced by vinblastine and chromatin dispersal to the periphery of nuclei produced by doxorubicin. In summary, whilst the platinum(IV) derivatives were able to produce cytotoxicity via apoptosis, the introduction of a stable axial group significantly retarded the rate at which this occurred.

KW - Apoptosis

KW - Chemotherapy

KW - Platinum drugs

KW - Solid tumour models

UR - http://www.scopus.com/inward/record.url?scp=0344687262&partnerID=8YFLogxK

UR - https://www.sciencedirect.com/journal/biochemical-pharmacology

U2 - 10.1016/j.bcp.2003.07.016

DO - 10.1016/j.bcp.2003.07.016

M3 - Article

VL - 67

SP - 17

EP - 30

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 1

ER -